Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of IDP-124 Lotion in Moderate to Severe Atopic Dermatitis
NCT03058783Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Aug 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD), sponsored by Valeant Pharmaceuticals. Started Aug 2018; status: completed.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03058783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03058783.